Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated（LGND）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
lgnd · 股价预测 · 17 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 17 位华尔街分析师
Buy
17 位分析师
共识
评级分布
12 个月目标价
High
$289
Consensus
$268
+12.4% upside
Low
$252
Median: $265 · Last Close: $238.19
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$267.75
12.4% upside
High Target
$289
21.3%
Low Target
$252
5.8%
Current Price
$238.19
as of today
Based on analyst price targets, the LGND stock price prediction for the next 12 months ranges from $252 to $289. The consensus LGND price forecast of $267.75 implies 12.4% upside from the current price of $238.19.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $244.03 | ↑ 2.46% |
1-day model range: $242.81–$245.26. Peak: $245.26 (+2.46%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $429 | +80.0% |
| 2028 | $635 | +166.4% |
| 2029 | $817 | +243.1% |
| 2030 | $958 | +302.4% |
| 2031 | — | +344.1% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · LGND · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-08 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-04-30 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-04-28 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-04-15 | Citigroup | Maintains | Buy→Buy |
| 2026-04-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-24 | Citigroup | Maintains | Buy→Buy |
| 2026-02-27 | Oppenheimer | Maintains | Outperform→Outperform |
| 2026-02-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-12-10 | RBC Capital | Maintains | Outperform→Outperform |
| 2025-12-10 | Stifel | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Ligand Pharmaceuticals Incorporated (LGND) stock. Of the recent 98 rating actions, 2 were upgrades and 8 were downgrades. 17 analysts currently cover LGND.
分析师推荐趋势
LGND analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 5 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$285M
↓ 34.3% YoY
Revenue Next Year
$363M
↑ 27.3% YoY
EPS This Year
$9.06
EPS Next Year
$11.13
↑ 22.9% YoY
EPS ForecastReported vs Estimated
Analysts forecast LGND EPS of $9.06 for the current fiscal year, based on estimates from 6 analysts. The LGND revenue forecast is $285M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
LGND 股价预测由两类独立数据源支撑：来自 17 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。LGND 的共识目标价为 $267.75（+12.4% 上行空间），分析师共识为 Buy。
LGND 的短期预测（明日）为 $244.03（+2.46%）。 LGND 对 2027 年的股价预测均值为 $429。 LGND 对 2030 年的预测区间为 $906–$1011。
Ligand Pharmaceuticals Incorporated 在 NASDAQ 上市，代码 LGND。LGND 在 2027 年的整体展望偏积极，在覆盖分析师中约 71% 对应 Buy 共识。
常见问题
LGND 预测 · 8 个问题根据 17 位华尔街分析师，LGND 的 12 个月平均目标价为 $267.75，最高 $289.00、最低 $252.00。若有图表，中位目标价可在上方查看。相对当前价 $238.19，隐含约 +12.4% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.